KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) EBIT Margin: 2009-2014

Historic EBIT Margin for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -336.35%.

  • Biocryst Pharmaceuticals' EBIT Margin rose 23876.00% to -119.80% in Q3 2015 from the same period last year, while for Sep 2015 it was -83.06%, marking a year-over-year increase of 11422.00%. This contributed to the annual value of -336.35% for FY2014, which is 15912.00% down from last year.
  • According to the latest figures from FY2014, Biocryst Pharmaceuticals' EBIT Margin is -336.35%, which was down 89.78% from -177.24% recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' EBIT Margin ranged from a high of -55.08% in FY2010 and a low of -336.35% during FY2014.
  • Moreover, its 3-year median value for EBIT Margin was -177.24% (2013), whereas its average is -214.16%.
  • As far as peak fluctuations go, Biocryst Pharmaceuticals' EBIT Margin slumped by 19,737bps in 2011, and later skyrocketed by 12,356bps in 2012.
  • Biocryst Pharmaceuticals' EBIT Margin (Yearly) stood at -55.08% in 2010, then tumbled by 19,737bps to -252.44% in 2011, then surged by 12,356bps to -128.89% in 2012, then tumbled by 4,835bps to -177.24% in 2013, then plummeted by 15,912bps to -336.35% in 2014.